EDITOR,—I am the parent of a child who had a brain tumour with a poor prognosis and who was treated at New York University by Professor Patrick Kelly. Consequently, I wish to comment on M C G Stevens and colleagues' concerns that apparently innovative treatments available outside Britain that offer better prospects for cure than treatments available in Britain have attracted media interest.1

Their article suggests that Britain is at the forefront in all areas of neurological research; …